1. Home
  2. MCW vs HROW Comparison

MCW vs HROW Comparison

Compare MCW & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mister Car Wash Inc.

MCW

Mister Car Wash Inc.

HOLD

Current Price

$6.99

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$38.28

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCW
HROW
Founded
1996
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MCW
HROW
Price
$6.99
$38.28
Analyst Decision
Hold
Strong Buy
Analyst Count
11
8
Target Price
$7.28
$69.86
AVG Volume (30 Days)
2.5M
470.3K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
47.62
N/A
EPS
0.31
N/A
Revenue
$1,051,731,000.00
N/A
Revenue This Year
$7.92
$31.79
Revenue Next Year
$7.05
$49.04
P/E Ratio
$22.55
N/A
Revenue Growth
5.73
N/A
52 Week Low
$4.61
$21.18
52 Week High
$7.81
$54.98

Technical Indicators

Market Signals
Indicator
MCW
HROW
Relative Strength Index (RSI) 63.49 53.06
Support Level $6.95 $36.23
Resistance Level $7.13 $41.49
Average True Range (ATR) 0.02 1.50
MACD -0.02 0.77
Stochastic Oscillator 70.00 87.80

Price Performance

Historical Comparison
MCW
HROW

About MCW Mister Car Wash Inc.

Mister Car Wash Inc is a car wash brand offering express exterior and interior cleaning services. Express Exterior Locations offers express exterior cleaning services and Interior Cleaning Locations offers both express exterior and interior cleaning services. The company recognizes revenue from activities related to providing car wash services at its car wash locations that are geographically diversified throughout the United States and have similar economic characteristics and nature of services.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: